Evidence map›Paper›PMID 25900173›Full record

Observational studyClinical infectious diseases : an official publication of the Infectious Diseases Society of America2015

Impact of daily cotrimoxazole on clinical malaria and asymptomatic parasitemias in HIV-exposed, uninfected infants.

Nicole L Davis, Eric J Barnett, William C Miller, Anna Dow, Charles S Chasela, Michael G Hudgens, Dumbani Kayira, Gerald Tegha, Sascha R Ellington, Athena P Kourtis and 3 more

Open access · bronzeAbstract readObservational Study
In one paragraph

Observational study in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 21 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Observational
  15. Article
  16. Article
  17. Malaria in a 2-Month-Old HIV-Exposed Nigerian Infant: Challenges of Care.Journal of the International Association of Providers of AIDS Care
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Nicole L DavisDepartment of Epidemiology, Gillings School of Global Public Health Division of Infectious Diseases, Department of Medicine, School of Medicine, University of North Carolina at Chapel Hill.
Eric J BarnettDivision of Infectious Diseases, Department of Medicine, School of Medicine, University of North Carolina at Chapel Hill.
William C MillerDepartment of Epidemiology, Gillings School of Global Public Health Division of Infectious Diseases, Department of Medicine, School of Medicine, University of North Carolina at Chapel Hill.
Anna DowDepartment of Epidemiology, Gillings School of Global Public Health.
Charles S ChaselaDivision of Epidemiology and Biostatistics, School of Public Health, University of Witwatersrand, Parktown, South Africa.
Michael G HudgensDepartment of Biostatistics, Gillings School of Global Public Health, University of North Carolina at Chapel Hill.
Dumbani KayiraUniversity of North Carolina, UNC Project, Lilongwe, Malawi.
Gerald TeghaUniversity of North Carolina, UNC Project, Lilongwe, Malawi.
Sascha R EllingtonDivision of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, Georgia.
Athena P KourtisDivision of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, Georgia.
Charles van der HorstDivision of Infectious Diseases, Department of Medicine, School of Medicine, University of North Carolina at Chapel Hill.
Denise J JamiesonDivision of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, Georgia.
Jonathan J JulianoDivision of Infectious Diseases, Department of Medicine, School of Medicine, University of North Carolina at Chapel Hill.
University of North Carolina at Chapel Hill · USCenters for Disease Control and Prevention · USUniversity of the Witwatersrand · ZA

Funding

Virology, Immunology, and Microbiology CoreP30AI050410 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DAVID M. MARGOLIS · 2001 to 2026
$76.9M
Fogarty International Clinical Research Scholars Support Center @ Vanderbilt-AAMCR24TW007988 · FIC · VANDERBILT UNIVERSITY · PI VERMUND, STEN H. · 2007 to 2011
$27.6M
UNC CENTER FOR HEALTH PROMOTION AND DISEASE PREVENTIONU48DP001944 · DP · UNIV OF NORTH CAROLINA CHAPEL HILL · PI AMMERMAN, ALICE S · 2009 to 2013
$15.1M
UNC Center for Health Promotion and Disease PreventionU48DP000059 · DP · UNIV OF NORTH CAROLINA CHAPEL HILL · PI AMMERMAN, ALICE S · 2004 to 2009
$14.4M
AIDS INTERNATIONAL TRAINING AND RESEARCH PROGRAMD43TW001039 · FIC · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ADIMORA, ADAORA A · 1998 to 2013
$9.9M
Training in Infectious Disease Epidemiology (TIDE)T32AI070114 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Brian W Pence · 2007 to 2026
$4.0M
Effects of Daily Cotrimoxazole on Malaria in HIV Exposed, Uninfected InfantsR03AI100694 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI JULIANO, JONATHAN J · 2013 to 2014
$152k
FIC NIH HHS 2-D43 TW01039-06FIC NIH HHS D43 TW001039FIC NIH HHS R24 TW007988NCCDPHP CDC HHS U48 DP000059NCCDPHP CDC HHS U48-DP000059-01NCCDPHP CDC HHS U48 DP001944NCCDPHP CDC HHS U48-DP001944-01NIAID NIH HHS 5T32AI070114NIAID NIH HHS P30 AI050410NIAID NIH HHS P30-AI50410NIAID NIH HHS R03 AI100694NIAID NIH HHS R03AI100694-A1NIAID NIH HHS T32 AI070114PHS HHS U48-CCU409660-09
6 · The paper itself

Abstract

backgroundCotrimoxazole preventive therapy (CPT) is recommended for all human immunodeficiency virus (HIV)-exposed infants to avoid opportunistic infections. Cotrimoxazole has antimalarial effects and appears to reduce clinical malaria infections, but the impact on asymptomatic malaria infections is unknown.

methodsWe conducted an observational cohort study using data and dried blood spots (DBSs) from the Breastfeeding, Antiretrovirals and Nutrition study to evaluate the impact of CPT on malaria infection during peak malaria season in Lilongwe, Malawi. We compared malaria incidence 1 year before and after CPT implementation (292 and 682 CPT-unexposed and CPT-exposed infants, respectively), including only infants who remained HIV negative by 36 weeks of age. Malaria was defined as clinical, asymptomatic (using DBSs at 12, 24, and 36 weeks), or a composite outcome of clinical or asymptomatic. Linear and binomial regression with generalized estimating equations were used to estimate the association between CPT and malaria. Differences in characteristics of parasitemias and drug resistance polymorphisms by CPT status were also assessed in the asymptomatic infections.

resultsCPT was associated with a 70% (95% confidence interval, 53%-81%) relative reduction in the risk of asymptomatic infection between 6 and 36 weeks of age. CPT appeared to provide temporary protection against clinical malaria and more sustained protection against asymptomatic infections, with no difference in parasitemia characteristics.

conclusionsCPT appears to reduce overall malaria infections, with more prolonged impacts on asymptomatic infections. Asymptomatic infections are potentially important reservoirs for malaria transmission. Therefore, CPT prophylaxis may have important individual and public health benefits.

Indexed as

AntimalarialsAsymptomatic InfectionsDrug ResistanceFemaleHIV InfectionsHumansInfantMalariaMalawiMaleParasitemiaPlasmodium falciparumRandom AllocationTrimethoprim, Sulfamethoxazole Drug CombinationAntimalarialsTrimethoprim, Sulfamethoxazole Drug Combinationantifolate resistancecotrimoxazoleHIVinfantmalaria

Identifiers

PMID25900173
PMCPMC4542924
OpenAlexW2135360915

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.